drugset / Trial / NCT06135155

A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations

NCT06135155

Phase 1 Completed 48 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.

Timeline

Start
2023-11-06
Primary completion
2023-12-04
Completion
2024-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject PEG-rhGH Protein / enzyme biologic Subcutaneous

Indications